149 related articles for article (PubMed ID: 37068919)
1. Risk factors for cataract in retinoblastoma management.
Jia S; Wen X; Yu J; Zhou M; Yang L; Feng Y; He X; Jia R; Fan J; Fan X
Br J Ophthalmol; 2024 Mar; 108(4):571-577. PubMed ID: 37068919
[TBL] [Abstract][Full Text] [Related]
2. Intra-arterial chemotherapy as primary or secondary treatment for infants diagnosed with advanced retinoblastoma before 3 months of age.
Chen Q; Zhang B; Dong Y; Mo X; Zhang L; Xia J; Zhang J; Zhang S
BMC Cancer; 2019 Jul; 19(1):693. PubMed ID: 31307410
[TBL] [Abstract][Full Text] [Related]
3. Rescue intra-arterial chemotherapy following retinoblastoma recurrence after initial intra-arterial chemotherapy.
Shields CL; Say EA; Pointdujour-Lim R; Cao C; Jabbour PM; Shields JA
J Fr Ophtalmol; 2015 Jun; 38(6):542-9. PubMed ID: 25982423
[TBL] [Abstract][Full Text] [Related]
4. Angiographic characteristics and treatment approach in patients undergoing intra-arterial chemotherapy for retinoblastoma.
Rusakevich AM; Nahhas MI; Zhou B; Dannenbaum MJ; Bretana ME; Schefler AC
Graefes Arch Clin Exp Ophthalmol; 2024 Apr; 262(4):1321-1328. PubMed ID: 38032379
[TBL] [Abstract][Full Text] [Related]
5. Ophthalmic Vascular Events after Primary Unilateral Intra-arterial Chemotherapy for Retinoblastoma in Early and Recent Eras.
Dalvin LA; Ancona-Lezama D; Lucio-Alvarez JA; Masoomian B; Jabbour P; Shields CL
Ophthalmology; 2018 Nov; 125(11):1803-1811. PubMed ID: 29921454
[TBL] [Abstract][Full Text] [Related]
6. Fluorescein angiographic findings after intra-arterial chemotherapy for retinoblastoma.
Bianciotto C; Shields CL; Iturralde JC; Sarici A; Jabbour P; Shields JA
Ophthalmology; 2012 Apr; 119(4):843-9. PubMed ID: 22137042
[TBL] [Abstract][Full Text] [Related]
7. Intra-arterial chemotherapy in refractory and advanced intraocular retinoblastoma.
Kumari N; Jain N; Saboo S; Parthasarathy R; Gupta V; Mahajan A; Das S
Indian J Ophthalmol; 2023 Feb; 71(2):436-443. PubMed ID: 36727336
[TBL] [Abstract][Full Text] [Related]
8. Incidence and Risk Factors for Neutropenia After Intra-Arterial Chemotherapy for Retinoblastoma.
Lee DH; Donkor R; Parvus MN; Dannenbaum MJ; Schefler AC
JAMA Ophthalmol; 2023 Dec; 141(12):1133-1138. PubMed ID: 37917073
[TBL] [Abstract][Full Text] [Related]
9. Intra-arterial Chemotherapy as Primary Treatment for Cavitary Retinoblastoma: Excellent Response in Eight Tumors.
Zheng Y; Froehler MT; Friedman DL; Daniels AB
Ophthalmol Retina; 2021 May; 5(5):479-485. PubMed ID: 32853834
[TBL] [Abstract][Full Text] [Related]
10. Intra-arterial chemotherapy for retinoblastoma in 70 eyes: outcomes based on the international classification of retinoblastoma.
Shields CL; Manjandavida FP; Lally SE; Pieretti G; Arepalli SA; Caywood EH; Jabbour P; Shields JA
Ophthalmology; 2014 Jul; 121(7):1453-60. PubMed ID: 24656794
[TBL] [Abstract][Full Text] [Related]
11. OPHTHALMIC VASCULAR EVENTS AFTER INTRA-ARTERIAL CHEMOTHERAPY FOR RETINOBLASTOMA: Real-World Comparison Between Primary and Secondary Treatments.
Ancona-Lezama D; Dalvin LA; Lucio-Alvarez JA; Jabbour P; Shields CL
Retina; 2019 Dec; 39(12):2264-2272. PubMed ID: 30204728
[TBL] [Abstract][Full Text] [Related]
12. Retrospective analysis of primarily treated group D retinoblastoma.
Kiratli H; Koç İ; Inam O; Varan A; Akyüz C
Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2225-2231. PubMed ID: 29961117
[TBL] [Abstract][Full Text] [Related]
13. Histopathology of retinoblastoma eyes enucleated after intra-arterial chemotherapy.
Biewald EM; Bornfeld N; Metz KA; Schlüter S; Kiefer T; Radbruch A; Göricke S; Sirin S; Ketteler P; Bechrakis NE
Br J Ophthalmol; 2020 Aug; 104(8):1171-1175. PubMed ID: 31676593
[TBL] [Abstract][Full Text] [Related]
14. Hematologic Complications Associated With Intra-arterial Chemotherapy for Retinoblastoma Treatment: A Single Institution Experience.
Sanati-Mehrizy A; Ghosh T; Peterson E; Starke RM; Harbour JW; Corrales-Medina FF
J Pediatr Hematol Oncol; 2022 May; 44(4):181-185. PubMed ID: 35446803
[TBL] [Abstract][Full Text] [Related]
15. Intra-Arterial Chemotherapy for Retinoblastoma: 8-Year Experience from a Tertiary Referral Institute in Thailand.
Rojanaporn D; Chanthanaphak E; Boonyaopas R; Sujirakul T; Hongeng S; Ayudhaya SSN
Asia Pac J Ophthalmol (Phila); 2019; 8(3):211-217. PubMed ID: 30714357
[TBL] [Abstract][Full Text] [Related]
16. Risk Factors for Acute Choroidal Ischemia after Intra-arterial Melphalan for Retinoblastoma: The Role of the Catheterization Approach.
Stathopoulos C; Bartolini B; Marie G; Beck-Popovic M; Saliou G; Munier FL
Ophthalmology; 2021 May; 128(5):754-764. PubMed ID: 32956742
[TBL] [Abstract][Full Text] [Related]
17. Evaluating primary intra-arterial chemotherapy versus intravenous plus intra-arterial chemotherapy for advanced intraocular retinoblastoma.
Chen Q; Zhang B; Dong Y; Mo X; Zhang L; Xia J; Zhang J; Zhang S
Cancer Chemother Pharmacol; 2020 Apr; 85(4):723-730. PubMed ID: 32123960
[TBL] [Abstract][Full Text] [Related]
18. Minimal exposure (one or two cycles) of intra-arterial chemotherapy in the management of retinoblastoma.
Shields CL; Kaliki S; Shah SU; Bianciotto CG; Liu D; Jabbour P; Griffin GC; Shields JA
Ophthalmology; 2012 Jan; 119(1):188-92. PubMed ID: 21975042
[TBL] [Abstract][Full Text] [Related]
19. The Addition of Topotecan to Melphalan in the Treatment of Retinoblastoma with Intra-arterial Chemotherapy.
Stacey AW; De Francesco S; Borri M; Hadjistilianou T
Ophthalmol Retina; 2021 Aug; 5(8):824-830. PubMed ID: 33221516
[TBL] [Abstract][Full Text] [Related]
20. Management of advanced retinoblastoma with intravenous chemotherapy then intra-arterial chemotherapy as alternative to enucleation.
Shields CL; Kaliki S; Al-Dahmash S; Rojanaporn D; Leahey A; Griffin G; Jabbour P; Shields JA
Retina; 2013; 33(10):2103-9. PubMed ID: 23873161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
